pharma news today obesity glp-1 The Multi-Sector Impacts of GLP-1RA Drugs New weight-loss drugs surge in

doi: 10.1186/s12933-025-02607-w 32 BaggioLLYustaBMulvihillEECaoXStreutkerCJButanyJet al

Brazilian Journal of Pharmaceutical Sciences, 55

Across all characteristics, there were no significant differences observed between patients with low and normal free carnitine levels at baseline

A.FigueroaA.NavaeiN.WongA.KalfonR.OrmsbeeL

Research investigations involving BPC-157 have examined its effects on nitric oxide (NO) synthase expression and NO-mediated signaling in vascular and mucosal tissue cell models, FAK-paxillin pathway involvement in cell migration assays, and VEGFR2 receptor activation dynamics in in vitro angiogenesis models

15, 16 GLP-1, endogenously produced in the L-cells of the distal ileum and colon, modulates appetite leading to decreased food intake and thus body weight